Yau Tsz-Kok, Soong Inda S, Sze Henry, Choi Cheuk-Wai, Yeung Mei-Wan, Ng Wai-Tong, Lee Anne W M
Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):98-103. doi: 10.1016/j.ijrobp.2008.07.066. Epub 2008 Dec 26.
Breast conservation treatment (BCT) was quite unpopular in Hong Kong until the early 1990s, but the trends and patterns of BCT use in the past 14 years have not been studied since. The purpose of this study was to identify the latest trends and patterns.
All consecutive cases of female breast cancer referred to a community oncology center in Hong Kong between 1994 and 2007 were retrospectively reviewed. Of the 2,375 women with T1-2 invasive breast cancer who underwent surgery, 1,137 (48%) had T1 (</=2 cm) disease and 1,238 (52%) had T2 (>2 cm-</=5 cm) disease. Median patient age was 51 years (range, 24-95 years); 65% patients had their surgery in public hospitals.
Of the total patient cohort, 2,153 (91%) patients presented with palpable breast masses and only 104 (4%) with mammographically detected cancers. Overall, 721 (30%) and 1,654 (70%) patients underwent BCT and mastectomy, respectively. There was no significant increase in the BCT rates (31%, SD 5%; p = 0.804) or mammographic detection rates (5%, SD 1%; p = 0.125) in Hong Kong between 1994 and 2007. In multivariate analyses, age </=50 years (OR 2.479; p < 0.001), mammographically detected tumors (OR 1.868; p = 0.007), T1 tumors (OR 3.159; p < 0.001), surgeries in private hospitals (OR 1.288; p = 0.018), and negative nodal status (OR 1.886; p < 0.001) were independent factors predictive of a higher likelihood of a woman having BCT.
Our results indicate a satisfactory acceptance of BCT by patients who are young and have small tumors, node-negative disease, or surgery in private hospitals. However, the continuing unpopularity of breast screening is likely a major factor limiting the broad use of BCT.
在20世纪90年代初之前,保乳治疗(BCT)在香港并不受欢迎,但自那以后的14年里,BCT的使用趋势和模式尚未得到研究。本研究的目的是确定最新的趋势和模式。
回顾性分析了1994年至2007年间转诊至香港一家社区肿瘤中心的所有连续女性乳腺癌病例。在2375例接受手术的T1-2期浸润性乳腺癌女性中,1137例(48%)患有T1(≤2 cm)疾病,1238例(52%)患有T2(>2 cm-≤5 cm)疾病。患者年龄中位数为51岁(范围24-95岁);65%的患者在公立医院接受手术。
在整个患者队列中,2153例(91%)患者表现为可触及的乳腺肿块,只有104例(4%)通过乳腺X线摄影检测出癌症。总体而言,分别有721例(30%)和1654例(70%)患者接受了保乳治疗和乳房切除术。1994年至2007年间,香港的保乳治疗率(31%,标准差5%;p = 0.804)或乳腺X线摄影检测率(5%,标准差1%;p = 0.125)均无显著增加。在多因素分析中,年龄≤50岁(OR 2.479;p < 0.001)、乳腺X线摄影检测出的肿瘤(OR 1.868;p = 0.007)、T1期肿瘤(OR 3.159;p < 0.001)、在私立医院接受手术(OR 1.288;p = 0.018)以及淋巴结阴性状态(OR 1.886;p < 0.001)是预测女性接受保乳治疗可能性较高的独立因素。
我们的结果表明,年轻、肿瘤较小、淋巴结阴性疾病或在私立医院接受手术的患者对保乳治疗的接受度令人满意。然而,乳腺筛查持续不受欢迎可能是限制保乳治疗广泛应用的主要因素。